Newbury Pharmaceuticals AB
Research Newbury Pharmaceuticals AB (NEWBRY) on Bullrun: market cap SEK 83.29M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNEWBRY
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencySEK
- Market capSEK 83.29M
- Financial periodQ3 2026
- RevenueSEK 9.37M
- Net income-SEK 5.01M
- Gross margin39.2%
Valuation Snapshot
latest market cap is SEK 83.29M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 38.04M | -SEK 21.54M | n/a | 39.0% | n/a | SEK 7.92M | n/a | SEK 35.85M |
| FY2024 | SEK 24.61M | -SEK 21.78M | n/a | 49.9% | n/a | SEK 19.43M | n/a | SEK 46.77M |
| FY2023 | SEK 11.17M | -SEK 19.42M | n/a | 43.5% | n/a | SEK 8.53M | n/a | n/a |
| FY2022 | SEK 7.23M | -SEK 14.68M | n/a | 45.4% | n/a | SEK 33.33M | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | SEK 83.29M | n/a | n/a | n/a |
About Newbury Pharmaceuticals AB
Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden and the Scandinavian market. It offers oncology, rare diseases, neurology, and other treatment products. Newbury Pharmaceuticals AB (publ) was incorporated in 2020 and is based in Lund, Sweden.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Newbury Pharmaceuticals AB's market cap?
Newbury Pharmaceuticals AB's market capitalization is SEK 83.29M.
What does Newbury Pharmaceuticals AB do?
Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden and the Scandinavian market. It offers oncology, rare diseases, neurology, and other treatment products. Newbury Pharmaceuticals AB (publ) was incorporated in 2020 and is based in Lund, Sweden.